EDGAR Filing Documents for 0001654954-18-001973

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

SEC Accession No. 0001654954-18-001973

Filing Date

2018-02-28

Accepted

2018-02-28 17:09:29

Documents

Period of Report

2016-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K/A	oxis_10k.htm	10-K/A	937149
2	CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF	ex_311.htm	EX-31.1	17935
3	CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF	ex_312.htm	EX-31.2	17871
4	CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE	ex_321.htm	EX-32.1	7416
5	CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE	ex_322.htm	EX-32.2	7492
	Complete submission text file	0001654954-18-001973.txt		2964739

Data Files

Seq	Description	Document	Type	Size
6	XBRL INSTANCE DOCUMENT	gtbp-20161231.xml	EX-101.INS	477249
7	XBRL TAXONOMY EXTENSION SCHEMA	gtbp-20161231.xsd	EX-101.SCH	23626
8	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	gtbp-20161231_cal.xml	EX-101.CAL	36917
9	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	gtbp-20161231_def.xml	EX-101.DEF	53071
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE	gtbp-20161231_lab.xml	EX-101.LAB	185405
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	gtbp-20161231_pre.xml	EX-101.PRE	143348

Mailing Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602

Business Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602 (800) 304-9888

GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)